Interfering with cancer: a brief outline of advances in RNA interference in oncology (Q35997754)

11 August 2017

1 reference

title

Interfering with cancer: a brief outline of advances in RNA interference in oncology (English)

1 reference

11 August 2017

1 reference

P D Rye

1

1 reference

11 August 2017

T Stigbrand

series ordinal

2

1 reference

11 August 2017

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

25

1 reference

11 August 2017

issue

5-6

1 reference

11 August 2017

page(s)

329-336

1 reference

https://scigraph.springernature.com/pub.10.1159/000081403

11 August 2017

exact match

0 references

cites work

N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cells

1 reference

E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells

21 January 2018

1 reference

Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer

21 January 2018

1 reference

Targeting tumor cells by enhancing radiation sensitivity

21 January 2018

1 reference

Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer

21 January 2018

1 reference

Engineering antibodies for clinical applications in cancer

21 January 2018

1 reference

Photochemical internalisation: a novel drug delivery system

21 January 2018

1 reference

Intraoperative MR imaging

21 January 2018

1 reference

Antisense approaches in prostate cancer

21 January 2018

1 reference

Applying antisense technology: Affinitak and other antisense oligonucleotides in clinical development

21 January 2018

1 reference

Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells

21 January 2018

1 reference

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

Argonaute2 is the catalytic engine of mammalian RNAi

21 January 2018

1 reference

Crystal structure of Argonaute and its implications for RISC slicer activity

21 January 2018

1 reference

Effective expression of small interfering RNA in human cells

21 January 2018

1 reference

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

21 January 2018

1 reference

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

Gene silencing by adenovirus-delivered siRNA.

21 January 2018

1 reference

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

21 January 2018

1 reference

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

Pathways of apoptotic and non-apoptotic death in tumour cells

21 January 2018

1 reference

Survivin Gene Expression Positively Correlates with Proliferative Activity of Cancer Cells in Esophageal Cancer

21 January 2018

1 reference

Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).

21 January 2018

1 reference

Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line

21 January 2018

1 reference

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

21 January 2018

1 reference

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

21 January 2018

1 reference

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells

21 January 2018

1 reference

Ras interference as cancer therapy

21 January 2018

1 reference

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

21 January 2018

1 reference

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

21 January 2018

1 reference

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity

21 January 2018

1 reference

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

21 January 2018

1 reference

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

siRNA-mediated gene silencing in vitro and in vivo.

21 January 2018

1 reference

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.

21 January 2018

1 reference

Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status.

21 January 2018

1 reference

MicroRNAs modulate hematopoietic lineage differentiation

21 January 2018

1 reference

Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein

21 January 2018

1 reference

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

21 January 2018

1 reference

Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.

21 January 2018

1 reference

Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000081403

1 reference

Dimensions Publication ID

11 August 2017

1040106989

0 references

1 reference